Infectious Disease | Active Outbreak | Last updated May 8, 2026
Editor’s note
This is a developing story. The outbreak described in this article is ongoing as of publication. All figures, locations, and case counts reflect confirmed reporting as of May 8, 2026. Details may change.
On April 6, 2026, a 70-year-old Dutch man standing somewhere in the South Atlantic Ocean began to feel unwell. Fever. Headache. Abdominal pain. Diarrhea. The kinds of symptoms that, on any ocean voyage, could be explained a hundred different ways: motion sickness, a stomach bug, something he ate at the last port.
Five days later, on April 11, he was dead.
He died aboard the MV Hondius, a Dutch-flagged expedition cruise ship carrying 147 passengers and crew. The vessel was somewhere between Ushuaia, Argentina, and the remote British Overseas Territory of Saint Helena, cutting through some of the most isolated waters on the planet. There was no diagnostic laboratory on board. There was no way to confirm what had killed him. His body was stored in a shipboard freezer. The voyage continued.
It would be another three weeks before the world learned what was already spreading.
The Ship
The MV Hondius is operated by Oceanwide Expeditions, a Dutch company specializing in polar and remote-destination voyages. The ship is a modern, purpose-built polar expedition vessel with an ice-strengthened hull, and it is designed for exactly the kind of itinerary it was running: leaving Ushuaia, the southernmost city in the world, on April 1, 2026, for a voyage that would take it to Antarctica, South Georgia Island, Tristan da Cunha, Saint Helena, Ascension Island, and eventually the Canary Islands.
These are not tourist destinations in the conventional sense. They are among the most remote places on Earth. Tristan da Cunha is the most isolated permanently inhabited island in the world, located roughly 2,800 kilometres from the nearest land. Saint Helena is where Napoleon Bonaparte spent his final years in exile. Ascension Island has a population of fewer than 1,000 people and no commercial airport with regular scheduled service.
The passengers who choose voyages like this are typically older, experienced travellers, often naturalists and wildlife enthusiasts. Many come for the birdwatching. The two Dutch citizens who appear to have been the first cases on board had spent the four months before boarding on a road trip through Argentina, Chile, and Uruguay, specifically for birdwatching, visiting sites in Patagonia where a species of rat known to carry the Andes virus was present.
Critical epidemiological clue
That detail, reported by Argentine investigators on May 6, is the most important piece of epidemiological information in this entire story. The Dutch couple almost certainly contracted the virus not on the ship, but in the Argentine wilderness, weeks before they boarded.
The Virus
Hantaviruses are not new. They are a family of rodent-borne viruses in the Hantaviridae family, and they have been infecting humans for as long as humans have been around rodents. The name comes from the Hantan River in South Korea, where a severe kidney disease called Korean hemorrhagic fever was traced to the Hantaan virus after the Korean War, a conflict in which thousands of United Nations troops were affected by an illness that baffled military physicians.
In Europe and Asia, hantaviruses primarily cause hemorrhagic fever with renal syndrome, or HFRS: a disease characterized by high fever, bleeding, and progressive kidney failure. In the Americas, a different set of hantavirus strains causes a different and, in many cases, more rapidly lethal condition called hantavirus cardiopulmonary syndrome, or HCPS. Rather than attacking the kidneys, HCPS attacks the lungs and heart.
In the Americas, hantaviruses can cause hantavirus cardiopulmonary syndrome, a severe respiratory illness, with a case fatality rate up to 50%. Hantavirus infections are relatively uncommon globally but are associated with a case fatality rate of under 1 to 15% in Asia and Europe and up to 50% in the Americas.
The Andes virus, the strain involved in the MV Hondius outbreak, sits at the deadlier end of this spectrum. Case fatality rates of Andes virus-induced HPS are approximately 40%. Nearly two in five people who develop cardiopulmonary syndrome from this virus die from it.
And it has one additional property that separates it from every other hantavirus on Earth.
Why Andes virus is different
Andes virus, found in South America, is the only currently known hantavirus for which limited human-to-human transmission among contacts has been documented.
Every other hantavirus is purely a zoonotic disease: it jumps from rodents to humans and stops there. The Andes virus does not always stop there. In cases of close, prolonged contact, it can pass from one infected person to another, an ability documented in previous outbreaks in Argentina and Chile involving household members, intimate partners, and healthcare workers. On a ship with 147 people sharing confined living and dining spaces for weeks at a time, that property is exactly what made this outbreak a genuine international emergency.
How the Andes Virus Kills
Understanding why this virus has a 40% case fatality rate requires understanding what it does inside the body.
Hantavirus pulmonary syndrome is characterized by fever, muscle aches, and headaches, rapidly progressing to pulmonary edema due to microvascular leakage, and to respiratory failure or shock.
The mechanism is as brutal as it sounds. The Andes virus primarily targets the endothelial cells lining the tiny capillaries of the lungs. These capillaries are the biological boundary between the bloodstream and the air spaces of the lung. When the virus infects them, it triggers an immune response so intense that the capillary walls begin to leak. Fluid from the bloodstream pours into the air sacs of the lung, the alveoli. The patient begins to drown in their own fluids from the inside.
This process can move with terrifying speed. Some patients with the Andes strain can deteriorate within hours. And the cruel paradox at the heart of the disease is that the killing is partly done by the body’s own defenses. A lot of these viruses end up killing people not just from the infection itself but from the body’s own immune response. The inflammatory cascade the immune system launches against the virus also damages the very tissue it is trying to protect.
In about 50% of infections, the initial fever and body aches are followed by a swift progression to the cardiopulmonary phase, characterized by shortness of breath, cough, rapid heart rate, and low blood pressure as a consequence of rapidly progressing pulmonary edema due to capillary leakage. Cardiogenic shock is the main cause of death, which may occur within hours of the cardiopulmonary phase.
The incubation period, the time between infection and the first symptoms, ranges from one to eight weeks, with HPS symptoms most commonly appearing two to four weeks after exposure. HCPS has an incubation period ranging from 10 to 49 days, followed by a febrile prodrome including fever, myalgia, and headache. Patients can then rapidly progress to a cardiopulmonary phase, which can end in cardiogenic shock, respiratory failure, and death.
This long incubation window is precisely what made the MV Hondius outbreak so difficult to detect and contain. People exposed weeks earlier on a birdwatching trip in Argentina had already been aboard a ship for weeks before showing symptoms. By the time the first person died, others may already have been incubating the infection.
There Is No Treatment
This needs to be stated plainly because it shapes everything about how this outbreak has been managed.
No vaccine. No approved antiviral.
There is no licensed specific antiviral treatment or vaccine for hantavirus infection. Care is supportive and focuses on close clinical monitoring and management of respiratory, cardiac and kidney complications.
There are no antivirals approved for this disease. Attempts to treat HPS with intravenous ribavirin have been ineffective after hospitalization, indicating that the final clinical stages of HPS progress too rapidly for ribavirin to exert an antiviral effect.
It is important for people with HPS to begin treatment as early as possible to improve their chances of recovery. HPS is fatal in nearly 4 in 10 people who are infected. Early intensive medical care is critical because patients who have sudden acute disease can rapidly become severely sick and die.
Supportive care, which means mechanical ventilation to keep the lungs working, vasopressors to maintain blood pressure, careful fluid management, and intensive nursing, can make the difference between survival and death if started early enough. But it requires an intensive care unit. It requires specialist physicians. It requires the full infrastructure of a tertiary-care hospital.
A ship in the middle of the South Atlantic Ocean has none of these things.
The Timeline of a Slow-Motion Crisis
What unfolded aboard the MV Hondius between early April and early May 2026 is a case study in how a novel outbreak in a remote setting can evade detection until it has already spread across multiple countries.
On November 27, 2025, the index case began a four-month road trip spanning Chile, Uruguay, and Argentina. On April 1, 2026, the MV Hondius departed Ushuaia, Argentina, with 147 to 149 people aboard. On approximately April 6, the earliest symptom onset occurred. On April 11, the first death occurred aboard the ship, but hantavirus was not yet confirmed.
The first death on the ship was a man who developed symptoms on April 6 and died five days later. No samples were taken, and hantavirus was not identified because the symptoms were similar to other viruses.
This is the first and most consequential missed window. A 70-year-old man dies of fever and respiratory distress on an Antarctic cruise ship. Without laboratory testing, there is no way to distinguish this from influenza, bacterial pneumonia, or any number of other causes of acute respiratory illness in an older traveller. His death is tragic, but it is not immediately alarming in a way that triggers an international response.
On April 24, the Dutch man’s body was taken off the ship, two weeks after his death, when the ship came to the British Overseas Territory of Saint Helena. At this point, approximately 30 to 40 passengers disembarked at Saint Helena. Among them was the man’s wife.
She was already sick.
Case 2, an adult female who was a close contact of Case 1, went ashore at Saint Helena on April 24 with gastrointestinal symptoms. She subsequently deteriorated during a flight to Johannesburg, South Africa, on April 25. She died upon arrival at the emergency department on April 26. On May 4, the case was subsequently confirmed by PCR with hantavirus infection.
That flight from Saint Helena to Johannesburg would become one of the most consequential events in the outbreak’s international spread. Eight French nationals who were not on the cruise were identified as close contacts after being on the same flight. One was displaying mild symptoms.
Meanwhile, a third case had emerged on the ship itself.
Case 3, an adult male, presented to the ship’s doctor on April 24 with febrile illness, shortness of breath, and signs of pneumonia. On April 26, his condition worsened. He was medically evacuated from Ascension Island to South Africa on April 27, where he was hospitalized in an intensive care unit. Laboratory PCR testing confirmed hantavirus infection on May 2, 2026.
Then on May 2, a fourth patient died. Case 4, an adult female with presentation of pneumonia, died on May 2, 2026. Onset of symptoms was on April 28, with fever and a general feeling of being unwell.
Also on May 2, the United Kingdom’s International Health Regulations focal point formally notified the World Health Organization of the cluster. The same day, laboratory testing in South Africa confirmed hantavirus in the critically ill Case 3.
Timeline lesson
From first death to WHO notification: 21 days. From WHO notification to international response: hours.
The International Scramble
What followed the WHO notification on May 2 was one of the most geographically complex public health coordination efforts triggered by a single outbreak cluster in recent memory.
The fact that nine EU/EEA member states had nationals aboard a Dutch-flagged vessel that originated in Argentina, stopped in Antarctica, South Georgia, Tristan da Cunha, Saint Helena, Ascension Island, and Cape Verde before heading to the Canary Islands meant that epidemiological contact tracing extended across six continents.
By May 4, the WHO had issued a formal Disease Outbreak Notice, DON599, reporting seven cases including two laboratory-confirmed and five suspected, three deaths, one critically ill patient in South Africa, and three individuals with mild symptoms still aboard.
On May 6, the Swiss government confirmed that a man infected with hantavirus was being treated in Zurich. Swiss authorities confirmed the patient was a passenger on the cruise ship, bringing the total number of infections to 8. The man was one of approximately 40 passengers who disembarked on April 26.
Three more patients, one a 56-year-old British national who was the ship’s doctor, one a 41-year-old Dutch national, and one a 65-year-old German national, were evacuated from the ship by air ambulance to the Netherlands for treatment. Two were crew members.
Authorities in Georgia, Arizona, California, Texas, and Virginia confirmed they were monitoring American residents who were on the ship and had since returned home. So far, none were showing symptoms.
In Singapore, two Singaporean residents, both men in their 60s, were self-isolating and being tested for hantavirus. In Canada, three people were self-isolating, including two in Ontario and one in Quebec.
Then came the crisis within the crisis.
The MV Hondius, with approximately 150 people still aboard, needed a port. The plan was to dock in Tenerife in the Canary Islands, a Spanish territory in the Atlantic, where passengers could disembark and receive care. The regional president of the Canary Islands, Fernando Clavijo, said no. Clavijo said he “cannot allow MV Hondius to enter the Canaries” out of concerns for the islanders’ safety, especially in light of their experiences in the COVID-19 pandemic.
The WHO pushed back directly. The WHO said that “Spain has a moral and legal obligation to assist these people, among whom are several Spanish citizens.”
As of May 8, the ship remained anchored off the coast of Cape Verde, whose health infrastructure the WHO described as insufficient to handle the scale of operation needed for a full evacuation.
The COVID Comparison: Why This Is Different
The situation captured international attention in ways that inevitably drew comparisons to the early days of the COVID-19 pandemic: a novel infectious illness, passengers dispersed across dozens of countries before the outbreak was understood, national governments refusing to accept the sick, and real uncertainty about transmission.
The comparison is understandable. It is also, according to every expert who has spoken publicly on the subject, fundamentally wrong.
Public risk assessment
WHO Director-General Tedros Adhanom Ghebreyesus said in a press briefing on May 7: “While this is a serious incident, WHO assesses the public health risk as low.”
There are several reasons for this assessment that are grounded in the biology of the Andes virus itself.
First, transmission requires close, prolonged contact. In previous outbreaks, transmission between people has been associated with long and prolonged contacts among household members, intimate partners, and healthcare workers. The Andes virus does not spread through casual contact, shared air on public transport, or brief encounters. It is not a respiratory pathogen in the COVID-19 sense.
Second, the virus appears genetically stable. There is no evidence that the Andes virus involved in this outbreak has mutated to become more transmissible. There is no reason to believe that the Andes virus has mutated into a more transmissible variant.
Third, the largest previous Andes virus outbreak on record remained contained. One of the largest documented Andes virus outbreaks occurred in 2018 in Patagonia, Argentina, and resulted in 34 cases and 11 deaths. Thirty-four cases. Not thousands, not millions. Thirty-four, even in an area where the virus is endemic.
Fourth, WHO said that while it expects more cases to emerge, it does not anticipate a large epidemic anywhere similar to COVID, and underlined that there is no evidence of a widespread transmission risk.
The public health concern is real. The pandemic concern is not.
The Birdwatching Hypothesis
Perhaps the most striking detail to emerge from the investigation, reported by Argentine authorities on May 6, is the leading hypothesis about how the index case became infected in the first place.
Two anonymous Argentine investigators claimed that the leading hypothesis was that the Dutch citizens who presented the first symptoms contracted the virus while birdwatching.
The first two cases “traveled through Argentina, Chile, and Uruguay on a bird-watching trip which included visits to sites where the species of rat known to carry the virus was present,” WHO Director-General Tedros told reporters.
This is not as surprising as it might sound. The Andes virus is carried by the long-tailed colilargo mouse, Oligoryzomys longicaudatus, a small rodent native to the Andean foothills and Patagonian steppe of Argentina and Chile. Birdwatchers and naturalists in these habitats often spend time in areas where these rodents are active: meadows, scrub, near streams and rocky areas. The virus is transmitted through inhalation of aerosols from infected rodent urine, feces, or saliva, not through rodent bites alone. Simply disturbing rodent-infested ground cover or picking up objects contaminated with dried rodent excretions can create a brief aerosol cloud sufficient for transmission.
The Argentine health ministry published a report showing the movements of the index case, the Dutch citizens who presented the first symptoms, prior to the ship’s departure, showing a four-month road trip spanning Chile, Uruguay, and Argentina from November 27, 2025, to April 1, 2026. The National Ministry of Health and Malbrán Institute are advancing the epidemiological investigation at the local level, including capture and testing of rodents along the Netherlanders’ travel route, as well as contact tracing.
If the hypothesis is correct, the index case was infected in the Argentine wilderness weeks before boarding the ship, carried the virus through the incubation period while the vessel sailed through Antarctic waters, and became symptomatic in one of the most remote and medically under-resourced locations on the planet. His wife, sharing a cabin with him day and night, contracted it through close contact. The third, fourth, and subsequent cases may represent either additional transmission from the couple before the first death, or new cases transmitted on board before isolation measures were in place.
Argentine authorities reported that no passengers showed symptoms of hantavirus at the time of the ship’s initial departure. This is consistent with an incubation period that had not yet run its course.
Where the Response Stands
As of May 8, 2026, the situation is as follows.
Aboard the MV Hondius, approximately 150 passengers and crew remain, anchored off Cape Verde, unable to disembark. The ship intended to proceed to Tenerife in the Canary Islands for evacuation, but was refused entry. Negotiations between the Dutch government, WHO, Spain, and Cape Verdean authorities are continuing.
Three patients confirmed or suspected to have hantavirus have been medically evacuated to hospitals in the Netherlands and Germany. One patient remains critically ill in an intensive care unit in South Africa. One patient is being treated in Zurich, Switzerland.
In the United States, the CDC assessed on May 7 that the risk to the American public was extremely low. Authorities in Georgia, Arizona, California, Texas, and Virginia are monitoring returning passengers. None were symptomatic as of the latest report.
Canada, France, Singapore, and multiple European countries are conducting contact tracing for passengers and flight contacts.
The Andes virus strain has been confirmed by PCR in multiple cases. Serology and genomic sequencing are ongoing, with the goal of establishing the precise phylogeny of the virus, confirming the source of infection, and identifying whether any mutations have occurred that might affect transmissibility or severity.
The WHO has formally notified all relevant States Parties under the International Health Regulations. The ECDC has activated the EU’s Early Warning and Response System.
What This Outbreak Reveals About Global Preparedness
The MV Hondius outbreak is not, epidemiologically, a major event. In raw numbers, eight cases and three deaths is a small cluster. It is not a public health emergency of international concern.
But it reveals structural vulnerabilities in the way the world detects and responds to novel infectious disease events that deserve serious attention.
The 21-day gap between the first death and the WHO notification reflects both the inherent difficulty of diagnosing a rare disease in a remote setting and the absence of adequate shipboard diagnostic capability. The outbreak timeline reveals a 22-day gap between the index case’s death on April 11 and the formal WHO notification on May 2, a window that reflects the inherent difficulty of diagnosing hantavirus from shipboard symptoms alone and the logistical reality of a vessel traveling through some of the most remote waters in the southern hemisphere, far from laboratory confirmation capabilities.
By the time PCR confirmation was achieved, the ship had traveled thousands of nautical miles, multiple passengers had disembarked across several port stops, and at least one infected person had boarded a commercial flight and been removed from the plane before takeoff.
This is the fundamental tension in managing infectious disease in the modern era of global travel. People move faster than pathogens can be diagnosed. A disease with a six-week incubation period and early symptoms indistinguishable from influenza is almost perfectly designed to slip through the net of border health measures and travel restrictions. The person who is about to become severely ill looks, feels, and tests as normal as anyone else when they board a plane or disembark from a ship.
No screening system available today could have caught this outbreak earlier than it was caught. What might help in the future is the deployment of rapid, point-of-care diagnostic capability on vessels operating in remote regions, combined with protocols for escalating unexplained respiratory deaths directly to national health authorities regardless of the apparent cause.
Protecting Yourself: What the Evidence Actually Shows
For the overwhelming majority of people reading this, the MV Hondius outbreak poses no personal risk. The WHO, CDC, and ECDC are unanimous on this.
For travellers planning expeditions to areas where the Andes virus is endemic, principally the Andean foothills and Patagonian steppe of Argentina and Chile, the prevention guidance is straightforward and evidence-based.
Avoid contact with wild rodents and their excretions. Do not handle or disturb rodent nests or burrows. When camping in rodent-endemic areas, keep food in sealed containers and do not sleep directly on the ground. Avoid dusty areas where rodent excretions may be aerosolized. If you must work in potentially contaminated environments, use N95 or equivalent respiratory protection and disposable gloves.
If you develop fever, muscle aches, or respiratory symptoms within eight weeks of travel to areas where the Andes virus is known to circulate, seek medical care immediately and inform the clinician of your travel history. Early intensive care is the only intervention that meaningfully improves outcomes. If HPS is suspected, the patient needs emergency medical care immediately, preferably in the intensive care unit, even before diagnosis. Early intensive medical care is critical because patients who have sudden acute disease can rapidly become severely sick and die.
Practical takeaway
There is no vaccine. There is no antiviral. Speed of diagnosis and the quality of supportive care are everything.
A Final Note on the Passengers Still Aboard
Somewhere in the South Atlantic, anchored off an island that is not equipped to help them, 150 people are waiting to go home.
Some of them are frightened. Some of them are watching their shipmates get airlifted away in stretchers. Some of them have been told by multiple countries that they are not welcome in port. Some of them came on this voyage because they love birds and wild places and the particular peace that comes from sailing through Antarctic waters.
None of them expected this.
The WHO Director-General said it plainly: Spain has a moral and legal obligation to assist these people. The passengers of the MV Hondius did not choose to be exposed to a rare rodent-borne pathogen in the Argentine wilderness. They are not a threat to anyone who does not spend days in close contact with a severely ill person. They are travellers, mostly elderly, in an increasingly frightening situation that public health authorities are racing to resolve.
The science is clear. The risk to the global public is low. The risk to the people on that ship, for as long as they remain stranded, is not.
This article will be updated as the situation develops.
Sources:
WHO Disease Outbreak Notice DON599, May 4, 2026.
Wikipedia: MV Hondius Hantavirus Outbreak, updated May 6, 2026.
CNN: “From US to Singapore, countries race to track hantavirus.” May 7, 2026.
Al Jazeera: “WHO confirms five cases of hantavirus linked to cruise ship.” May 7, 2026.
TODAY.com: “Could the Hantavirus Lead to a Pandemic? Experts Explain the Risk Level.” May 7, 2026.
NBC News: “What is the Andes virus? The hantavirus linked to a cruise ship outbreak is among the deadliest strains.” May 7, 2026.
Africa CDC Statement, May 5, 2026.
CDC Clinician Brief: Hantavirus Pulmonary Syndrome.
Chiang CF et al., “Small Interfering RNA Inhibition of Andes Virus Replication.” PLOS ONE, 2014. DOI: 10.1371/journal.pone.0099764
0 Comments